FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
06/24/2026
Back to search
Official data from USPTO
HIRUNDO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
HIRUNDO
ST13
US500000079421230Class
1, 5, 35, 42, 44
Filing
79421230
Registration
8182268
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
33
Latest update
06/24/2026
Trademark type
Word
Nice classes
1, 5, 35, 42, 44
Filing date
12/02/2024
Registration date
03/24/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/24/2026
Last transaction
06/24/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
33
Owner location
BE
Examiner
SOUDERS, MICHAEL J
Law office
M60
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
H. B. (pessoa física)
B. P. (pessoa física)
D. V. (pessoa física)
Representatives
Rebecca Liebowitz Venable LLP
Technical classification
Nice Classes
Class 1Class 5Class 35Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Chemicals for industrial purposes and chemical preparations for scientific purposes; chemical reagents for scientific purposes in the field of molecular biology; bacterial preparations other than for medical or veterinary use; enzymes and enzyme preparations for industrial use; chemical preparations for analyses in laboratories for scientific useother than for medical or veterinary purposes; biochemical preparations for scientific purposes; Chemical substances for analyses in laboratoriesother than for medical or veterinary purposesfor use in the research and development and production of drugsmedicinal and pharmaceutical preparations; chemical additives for use in the manufacturing of pharmaceuticals
Class 5
Pharmaceutical preparations and substances in the field of gynecology and women's healthendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; medicinal preparations for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; medicines for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; biochemical medicines for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; pharmaceutical preparations for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractInflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions for use in the field of gynecology and female health; estrogen preparations for therapeutic purposes; pharmaceutical preparations containing estrogen for the treatment and prevention of hormonal dysfunction and menopausal symptomsconditions and disordersendometriosisnoninflammatory disorders of female genital tractinflammatory diseases of female pelvic organsdisorders of breastbreast cancerovarian cancerendometrial cancervaginal cancercervical cancerfallopian tube cancerpolycystic ovarian syndromeneoplasm of uncertain or unknown behaviour of the uterus and ovarymenopauseinfertilityurinary tractcontraceptionuterine fibroids and postprocedural pelvic peritoneal adhesions; pharmaceutical preparations for the treatment of female hormonal dysfunction; pharmaceutical preparations for use in hormone replacement therapy; pharmaceutical preparations for the treatment of menopausal symptomsconditions and disorders
Class 35
Market research and business analysis services; business marketing consulting services in the field of pharmaceuticalbiotechnologybiochemicalmedical device and diagnostics industries; market analysis; providing business information and data processing services in the field of pharmaceuticalbiotechnologybiochemical medical devicediagnostics industries; compilation of statistics for business or commercial purposes in the field of biochemical medical devices
Class 42
Scientificclinical surgerymedical and life-science research; research and development in the field of biotechnology and biochemistry; research and development in the field of pharmaceuticalsbiopharmaceuticalsmedical devicesmedical diagnostics; research relating to molecular sciences; research and development in the field of drug development; testinganalysisevaluation of pharmaceutical and biochemical productsespecially for use in medicines; research and development of medicines; testing of pharmaceuticals; biotechnology research and development services; product development involving pharmaceutical products; medical and scientific researchconducting clinical trials as part of the research and development of pharmaceuticals and medicines; clinical research in the field of production of chemicals for pharmaceutical usepharmaceuticalsmedical devices and medical diagnostics; scientific researchproviding analysis of statistical data in the field of biotechnology; scientific researchproviding analysis of statistical data in the field of biotechnological diagnostics industries
Class 44
Medical services; providing medical advice in the field of efficacy of pharmaceuticals; provision of medical data relating to the use of pharmaceuticals; medical information online and on the internet relating to productssolutions and pharmaceutical and medical advances; medical information online and on the internet about productssolutionspharmaceutical or medical advances; providing medical research information in the field of pharmaceuticals
Publications
History of USPTO decisions and trademark events.
33 publications found
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
03/24/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/24/2026
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
02/27/2026
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
02/26/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/27/2026
PUBO
PUBLISHED FOR OPPOSITION
01/27/2026
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
01/21/2026
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/02/2026
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
01/02/2026
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
01/02/2026
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
01/02/2026
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/02/2026
XAEC
EXAMINER'S AMENDMENT ENTERED
01/02/2026
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
01/02/2026
GNEA
EXAMINERS AMENDMENT E-MAILED
01/02/2026
CNEA
EXAMINERS AMENDMENT -WRITTEN
01/02/2026
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
01/02/2026
GNFR
FINAL REFUSAL E-MAILED
01/02/2026
CNFR
FINAL REFUSAL WRITTEN
01/02/2026
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/30/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/30/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
12/30/2025
RFNT
REFUSAL PROCESSED BY IB
08/02/2025
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
07/14/2025
RFRR
REFUSAL PROCESSED BY MPU
07/14/2025
CHLD
CHANGE OF OWNER RECEIVED FROM IB
05/30/2025
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
05/22/2025
CNRT
NON-FINAL ACTION WRITTEN
05/21/2025
DOCK
ASSIGNED TO EXAMINER
05/21/2025
MAFR
APPLICATION FILING RECEIPT MAILED
04/11/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/11/2025
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
04/10/2025
Continuous trademark protection
Get notified about every new filing that threatens HIRUNDO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.